Poisoned Russian Spy Skripal `Improving Rapidly,' Hospital Says
(Bloomberg) -- Sergei Skripal, the former Russian double agent poisoned a month ago in southern England, is “improving rapidly,” according to the hospital treating him.
“He is responding well to treatment, improving rapidly and is no longer in a critical condition,” Christine Blanshard, medical director at Salisbury District Hospital, said Friday in a statement. It comes eight days after the hospital said the condition of Skripal's daughter, Yulia, was no longer critical.
U.K. Says ‘All Roads Lead to Russia' in Poisoned Spy Case
U.K. authorities have blamed Russia for the March 4 attack on the Skripals, after identifying the substance used as Novichok, a Soviet-era nerve agent. That led to the coordinated expulsions of more than 150 Russian diplomats by British allies including the U.S., Canada, Australia and European nations. Russia, for its part, has demanded proof and involvement in any investigation.
But the U.K. was forced onto the back foot this week when government scientists said they couldn't identify Russia as the source of the nerve agent. That contradicted earlier statements by Foreign Secretary Boris Johnson, leading Russia to accuse the U.K. of spinning “fairy tales.”
Prime Minister Theresa May's government maintains that its conclusion that Russia is responsible stems from analyzing intelligence alongside the laboratory's findings.
To contact the reporter on this story: Alex Morales in London at amorales2@bloomberg.net.
To contact the editors responsible for this story: Flavia Krause-Jackson at fjackson@bloomberg.net, Stuart Biggs, Mark Williams
©2018 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.